• レポートコード:QYR2104Z0909 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、99ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥546,000 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥819,000 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、菌血症検査のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(従来型血液培養検査、PCR法、核酸検査、質量分析、ポイントオブケア検査(POCT))、用途別市場規模(病院、独立診断センター、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・菌血症検査の市場動向 ・企業の競争状況、市場シェア ・菌血症検査の種類別市場規模(従来型血液培養検査、PCR法、核酸検査、質量分析、ポイントオブケア検査(POCT)) ・菌血症検査の用途別市場規模(病院、独立診断センター、その他) ・菌血症検査の北米市場規模2016-2027(アメリカ、カナダ) ・菌血症検査のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・菌血症検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・菌血症検査の中南米市場規模2016-2027(メキシコ、ブラジル) ・菌血症検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(BD、bioMérieux、Cepheid、Roche Diagnostics、IRIDICA、Bruker、Nanosphere、Siemens、AdvanDX) ・結論 |
BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests are SepsiTest, SeptiFast, MagicPlex, VYOO, and PLEX-ID. The global bloodstream infection testing market is driven by the growing incidence and prevalence of burn/wounds cases, HIV, pneumonia, pyelonephritis, and cancer. Additionally, awareness about hygiene, diagnosis rate, unhealthy lifestyle, and increase in geriatric population are the potential factors for the market growth. On the other hand, rigid regulatory scenario regarding diagnosis procedures, high diagnosis cost, and lack of medical reimbursement may hinder the growth of the market during the forecast period. Innovations, R&D investments, mergers and acquisitions among the key vendors are the dynamics for the bloodstream infection testing market to progress.
Market Analysis and Insights: Global Blood Stream Infection Testing Market
The global Blood Stream Infection Testing market size is projected to reach US$ 5862.7 million by 2026, from US$ 3679.1 million in 2019, at a CAGR of 6.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blood Stream Infection Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blood Stream Infection Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blood Stream Infection Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blood Stream Infection Testing market.
Global Blood Stream Infection Testing Scope and Market Size
Blood Stream Infection Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Stream Infection Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing
Segment by Application
Hospitals
Independent Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Stream Infection Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Conventional Blood Culture Tests
1.2.3 PCR Methods
1.2.4 Nucleic Acid Testing
1.2.5 Mass Spectroscopy
1.2.6 Point of Care Testing
1.3 Market by Application
1.3.1 Global Blood Stream Infection Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Independent Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Blood Stream Infection Testing Market Perspective (2016-2027)
2.2 Blood Stream Infection Testing Growth Trends by Regions
2.2.1 Blood Stream Infection Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Blood Stream Infection Testing Historic Market Share by Regions (2016-2021)
2.2.3 Blood Stream Infection Testing Forecasted Market Size by Regions (2022-2027)
2.3 Blood Stream Infection Testing Industry Dynamic
2.3.1 Blood Stream Infection Testing Market Trends
2.3.2 Blood Stream Infection Testing Market Drivers
2.3.3 Blood Stream Infection Testing Market Challenges
2.3.4 Blood Stream Infection Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Stream Infection Testing Players by Revenue
3.1.1 Global Top Blood Stream Infection Testing Players by Revenue (2016-2021)
3.1.2 Global Blood Stream Infection Testing Revenue Market Share by Players (2016-2021)
3.2 Global Blood Stream Infection Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Blood Stream Infection Testing Revenue
3.4 Global Blood Stream Infection Testing Market Concentration Ratio
3.4.1 Global Blood Stream Infection Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Stream Infection Testing Revenue in 2020
3.5 Blood Stream Infection Testing Key Players Head office and Area Served
3.6 Key Players Blood Stream Infection Testing Product Solution and Service
3.7 Date of Enter into Blood Stream Infection Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Stream Infection Testing Breakdown Data by Type
4.1 Global Blood Stream Infection Testing Historic Market Size by Type (2016-2021)
4.2 Global Blood Stream Infection Testing Forecasted Market Size by Type (2022-2027)
5 Blood Stream Infection Testing Breakdown Data by Application
5.1 Global Blood Stream Infection Testing Historic Market Size by Application (2016-2021)
5.2 Global Blood Stream Infection Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Blood Stream Infection Testing Market Size (2016-2027)
6.2 North America Blood Stream Infection Testing Market Size by Type
6.2.1 North America Blood Stream Infection Testing Market Size by Type (2016-2021)
6.2.2 North America Blood Stream Infection Testing Market Size by Type (2022-2027)
6.2.3 North America Blood Stream Infection Testing Market Size by Type (2016-2027)
6.3 North America Blood Stream Infection Testing Market Size by Application
6.3.1 North America Blood Stream Infection Testing Market Size by Application (2016-2021)
6.3.2 North America Blood Stream Infection Testing Market Size by Application (2022-2027)
6.3.3 North America Blood Stream Infection Testing Market Size by Application (2016-2027)
6.4 North America Blood Stream Infection Testing Market Size by Country
6.4.1 North America Blood Stream Infection Testing Market Size by Country (2016-2021)
6.4.2 North America Blood Stream Infection Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Blood Stream Infection Testing Market Size (2016-2027)
7.2 Europe Blood Stream Infection Testing Market Size by Type
7.2.1 Europe Blood Stream Infection Testing Market Size by Type (2016-2021)
7.2.2 Europe Blood Stream Infection Testing Market Size by Type (2022-2027)
7.2.3 Europe Blood Stream Infection Testing Market Size by Type (2016-2027)
7.3 Europe Blood Stream Infection Testing Market Size by Application
7.3.1 Europe Blood Stream Infection Testing Market Size by Application (2016-2021)
7.3.2 Europe Blood Stream Infection Testing Market Size by Application (2022-2027)
7.3.3 Europe Blood Stream Infection Testing Market Size by Application (2016-2027)
7.4 Europe Blood Stream Infection Testing Market Size by Country
7.4.1 Europe Blood Stream Infection Testing Market Size by Country (2016-2021)
7.4.2 Europe Blood Stream Infection Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Blood Stream Infection Testing Market Size (2016-2027)
8.2 Asia-Pacific Blood Stream Infection Testing Market Size by Type
8.2.1 Asia-Pacific Blood Stream Infection Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Blood Stream Infection Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Blood Stream Infection Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Blood Stream Infection Testing Market Size by Application
8.3.1 Asia-Pacific Blood Stream Infection Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Blood Stream Infection Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Blood Stream Infection Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Blood Stream Infection Testing Market Size by Region
8.4.1 Asia-Pacific Blood Stream Infection Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Blood Stream Infection Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Blood Stream Infection Testing Market Size (2016-2027)
9.2 Latin America Blood Stream Infection Testing Market Size by Type
9.2.1 Latin America Blood Stream Infection Testing Market Size by Type (2016-2021)
9.2.2 Latin America Blood Stream Infection Testing Market Size by Type (2022-2027)
9.2.3 Latin America Blood Stream Infection Testing Market Size by Type (2016-2027)
9.3 Latin America Blood Stream Infection Testing Market Size by Application
9.3.1 Latin America Blood Stream Infection Testing Market Size by Application (2016-2021)
9.3.2 Latin America Blood Stream Infection Testing Market Size by Application (2022-2027)
9.3.3 Latin America Blood Stream Infection Testing Market Size by Application (2016-2027)
9.4 Latin America Blood Stream Infection Testing Market Size by Country
9.4.1 Latin America Blood Stream Infection Testing Market Size by Country (2016-2021)
9.4.2 Latin America Blood Stream Infection Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Stream Infection Testing Market Size (2016-2027)
10.2 Middle East & Africa Blood Stream Infection Testing Market Size by Type
10.2.1 Middle East & Africa Blood Stream Infection Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Blood Stream Infection Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Blood Stream Infection Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Blood Stream Infection Testing Market Size by Application
10.3.1 Middle East & Africa Blood Stream Infection Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Blood Stream Infection Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Blood Stream Infection Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Blood Stream Infection Testing Market Size by Country
10.4.1 Middle East & Africa Blood Stream Infection Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Blood Stream Infection Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Blood Stream Infection Testing Introduction
11.1.4 BD Revenue in Blood Stream Infection Testing Business (2016-2021)
11.1.5 BD Recent Development
11.2 bioMérieux
11.2.1 bioMérieux Company Details
11.2.2 bioMérieux Business Overview
11.2.3 bioMérieux Blood Stream Infection Testing Introduction
11.2.4 bioMérieux Revenue in Blood Stream Infection Testing Business (2016-2021)
11.2.5 bioMérieux Recent Development
11.3 Cepheid
11.3.1 Cepheid Company Details
11.3.2 Cepheid Business Overview
11.3.3 Cepheid Blood Stream Infection Testing Introduction
11.3.4 Cepheid Revenue in Blood Stream Infection Testing Business (2016-2021)
11.3.5 Cepheid Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Details
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Blood Stream Infection Testing Introduction
11.4.4 Roche Diagnostics Revenue in Blood Stream Infection Testing Business (2016-2021)
11.4.5 Roche Diagnostics Recent Development
11.5 IRIDICA
11.5.1 IRIDICA Company Details
11.5.2 IRIDICA Business Overview
11.5.3 IRIDICA Blood Stream Infection Testing Introduction
11.5.4 IRIDICA Revenue in Blood Stream Infection Testing Business (2016-2021)
11.5.5 IRIDICA Recent Development
11.6 Bruker
11.6.1 Bruker Company Details
11.6.2 Bruker Business Overview
11.6.3 Bruker Blood Stream Infection Testing Introduction
11.6.4 Bruker Revenue in Blood Stream Infection Testing Business (2016-2021)
11.6.5 Bruker Recent Development
11.7 Nanosphere
11.7.1 Nanosphere Company Details
11.7.2 Nanosphere Business Overview
11.7.3 Nanosphere Blood Stream Infection Testing Introduction
11.7.4 Nanosphere Revenue in Blood Stream Infection Testing Business (2016-2021)
11.7.5 Nanosphere Recent Development
11.8 Siemens
11.8.1 Siemens Company Details
11.8.2 Siemens Business Overview
11.8.3 Siemens Blood Stream Infection Testing Introduction
11.8.4 Siemens Revenue in Blood Stream Infection Testing Business (2016-2021)
11.8.5 Siemens Recent Development
11.9 AdvanDX
11.9.1 AdvanDX Company Details
11.9.2 AdvanDX Business Overview
11.9.3 AdvanDX Blood Stream Infection Testing Introduction
11.9.4 AdvanDX Revenue in Blood Stream Infection Testing Business (2016-2021)
11.9.5 AdvanDX Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Blood Stream Infection Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Conventional Blood Culture Tests
Table 3. Key Players of PCR Methods
Table 4. Key Players of Nucleic Acid Testing
Table 5. Key Players of Mass Spectroscopy
Table 6. Key Players of Point of Care Testing
Table 7. Global Blood Stream Infection Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Blood Stream Infection Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Blood Stream Infection Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Blood Stream Infection Testing Market Share by Regions (2016-2021)
Table 11. Global Blood Stream Infection Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Blood Stream Infection Testing Market Share by Regions (2022-2027)
Table 13. Blood Stream Infection Testing Market Trends
Table 14. Blood Stream Infection Testing Market Drivers
Table 15. Blood Stream Infection Testing Market Challenges
Table 16. Blood Stream Infection Testing Market Restraints
Table 17. Global Blood Stream Infection Testing Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Blood Stream Infection Testing Market Share by Players (2016-2021)
Table 19. Global Top Blood Stream Infection Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Stream Infection Testing as of 2020)
Table 20. Ranking of Global Top Blood Stream Infection Testing Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Blood Stream Infection Testing Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Blood Stream Infection Testing Product Solution and Service
Table 24. Date of Enter into Blood Stream Infection Testing Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Blood Stream Infection Testing Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Blood Stream Infection Testing Revenue Market Share by Type (2016-2021)
Table 28. Global Blood Stream Infection Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Blood Stream Infection Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Blood Stream Infection Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Blood Stream Infection Testing Revenue Market Share by Application (2016-2021)
Table 32. Global Blood Stream Infection Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Blood Stream Infection Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Blood Stream Infection Testing Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Blood Stream Infection Testing Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Blood Stream Infection Testing Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Blood Stream Infection Testing Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Blood Stream Infection Testing Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Blood Stream Infection Testing Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Blood Stream Infection Testing Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Blood Stream Infection Testing Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Blood Stream Infection Testing Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Blood Stream Infection Testing Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Blood Stream Infection Testing Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Blood Stream Infection Testing Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Blood Stream Infection Testing Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Blood Stream Infection Testing Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Blood Stream Infection Testing Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Blood Stream Infection Testing Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Blood Stream Infection Testing Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Blood Stream Infection Testing Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Blood Stream Infection Testing Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Blood Stream Infection Testing Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Blood Stream Infection Testing Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Blood Stream Infection Testing Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Blood Stream Infection Testing Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Blood Stream Infection Testing Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Blood Stream Infection Testing Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Blood Stream Infection Testing Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Blood Stream Infection Testing Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Blood Stream Infection Testing Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Blood Stream Infection Testing Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Blood Stream Infection Testing Market Size by Country (2022-2027) & (US$ Million)
Table 64. BD Company Details
Table 65. BD Business Overview
Table 66. BD Blood Stream Infection Testing Product
Table 67. BD Revenue in Blood Stream Infection Testing Business (2016-2021) & (US$ Million)
Table 68. BD Recent Development
Table 69. bioMérieux Company Details
Table 70. bioMérieux Business Overview
Table 71. bioMérieux Blood Stream Infection Testing Product
Table 72. bioMérieux Revenue in Blood Stream Infection Testing Business (2016-2021) & (US$ Million)
Table 73. bioMérieux Recent Development
Table 74. Cepheid Company Details
Table 75. Cepheid Business Overview
Table 76. Cepheid Blood Stream Infection Testing Product
Table 77. Cepheid Revenue in Blood Stream Infection Testing Business (2016-2021) & (US$ Million)
Table 78. Cepheid Recent Development
Table 79. Roche Diagnostics Company Details
Table 80. Roche Diagnostics Business Overview
Table 81. Roche Diagnostics Blood Stream Infection Testing Product
Table 82. Roche Diagnostics Revenue in Blood Stream Infection Testing Business (2016-2021) & (US$ Million)
Table 83. Roche Diagnostics Recent Development
Table 84. IRIDICA Company Details
Table 85. IRIDICA Business Overview
Table 86. IRIDICA Blood Stream Infection Testing Product
Table 87. IRIDICA Revenue in Blood Stream Infection Testing Business (2016-2021) & (US$ Million)
Table 88. IRIDICA Recent Development
Table 89. Bruker Company Details
Table 90. Bruker Business Overview
Table 91. Bruker Blood Stream Infection Testing Product
Table 92. Bruker Revenue in Blood Stream Infection Testing Business (2016-2021) & (US$ Million)
Table 93. Bruker Recent Development
Table 94. Nanosphere Company Details
Table 95. Nanosphere Business Overview
Table 96. Nanosphere Blood Stream Infection Testing Product
Table 97. Nanosphere Revenue in Blood Stream Infection Testing Business (2016-2021) & (US$ Million)
Table 98. Nanosphere Recent Development
Table 99. Siemens Company Details
Table 100. Siemens Business Overview
Table 101. Siemens Revenue in Blood Stream Infection Testing Business (2016-2021) & (US$ Million)
Table 102. Siemens Recent Development
Table 103. AdvanDX Company Details
Table 104. AdvanDX Business Overview
Table 105. AdvanDX Blood Stream Infection Testing Product
Table 106. AdvanDX Revenue in Blood Stream Infection Testing Business (2016-2021) & (US$ Million)
Table 107. AdvanDX Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Stream Infection Testing Market Share by Type: 2020 VS 2027
Figure 2. Conventional Blood Culture Tests Features
Figure 3. PCR Methods Features
Figure 4. Nucleic Acid Testing Features
Figure 5. Mass Spectroscopy Features
Figure 6. Point of Care Testing Features
Figure 7. Global Blood Stream Infection Testing Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Independent Diagnostic Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Blood Stream Infection Testing Report Years Considered
Figure 12. Global Blood Stream Infection Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Blood Stream Infection Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Blood Stream Infection Testing Market Share by Regions: 2020 VS 2027
Figure 15. Global Blood Stream Infection Testing Market Share by Regions (2022-2027)
Figure 16. Global Blood Stream Infection Testing Market Share by Players in 2020
Figure 17. Global Top Blood Stream Infection Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Stream Infection Testing as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Blood Stream Infection Testing Revenue in 2020
Figure 19. Global Blood Stream Infection Testing Revenue Market Share by Type (2016-2021)
Figure 20. Global Blood Stream Infection Testing Revenue Market Share by Type (2022-2027)
Figure 21. North America Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Blood Stream Infection Testing Market Share by Type (2016-2027)
Figure 23. North America Blood Stream Infection Testing Market Share by Application (2016-2027)
Figure 24. North America Blood Stream Infection Testing Market Share by Country (2016-2027)
Figure 25. United States Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Blood Stream Infection Testing Market Share by Type (2016-2027)
Figure 29. Europe Blood Stream Infection Testing Market Share by Application (2016-2027)
Figure 30. Europe Blood Stream Infection Testing Market Share by Country (2016-2027)
Figure 31. Germany Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Blood Stream Infection Testing Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Blood Stream Infection Testing Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Blood Stream Infection Testing Market Share by Region (2016-2027)
Figure 41. China Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Blood Stream Infection Testing Market Share by Type (2016-2027)
Figure 49. Latin America Blood Stream Infection Testing Market Share by Application (2016-2027)
Figure 50. Latin America Blood Stream Infection Testing Market Share by Country (2016-2027)
Figure 51. Mexico Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Blood Stream Infection Testing Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Blood Stream Infection Testing Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Blood Stream Infection Testing Market Share by Country (2016-2027)
Figure 57. Turkey Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Blood Stream Infection Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. BD Revenue Growth Rate in Blood Stream Infection Testing Business (2016-2021)
Figure 61. bioMérieux Revenue Growth Rate in Blood Stream Infection Testing Business (2016-2021)
Figure 62. Cepheid Revenue Growth Rate in Blood Stream Infection Testing Business (2016-2021)
Figure 63. Roche Diagnostics Revenue Growth Rate in Blood Stream Infection Testing Business (2016-2021)
Figure 64. IRIDICA Revenue Growth Rate in Blood Stream Infection Testing Business (2016-2021)
Figure 65. Bruker Revenue Growth Rate in Blood Stream Infection Testing Business (2016-2021)
Figure 66. Nanosphere Revenue Growth Rate in Blood Stream Infection Testing Business (2016-2021)
Figure 67. Siemens Revenue Growth Rate in Blood Stream Infection Testing Business (2016-2021)
Figure 68. AdvanDX Revenue Growth Rate in Blood Stream Infection Testing Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed